Biodexa Pharmaceuticals Plc (NASDAQ:BDRX – Get Free Report) shares traded down 3.5% during trading on Monday . The stock traded as low as $1.24 and last traded at $1.38. 178,356 shares traded hands during mid-day trading, a decline of 70% from the average session volume of 595,523 shares. The stock had previously closed at $1.43.
Biodexa Pharmaceuticals Trading Down 3.5 %
The stock has a 50-day moving average of $2.34 and a 200 day moving average of $3.99.
Biodexa Pharmaceuticals Company Profile
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Featured Articles
- Five stocks we like better than Biodexa Pharmaceuticals
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Options Trading – Understanding Strike Price
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Consumer Discretionary Stocks Explained
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
